This guide is written for people who have been diagnosed with myeloma. It will also be helpful for their families, friends and health professionals....
Research Review
Multiple Myeloma Research Review
Highlights include: Real-life safety and efficacy of autologous SCT in elderly MM Lenalidomide maintenance vs. observation for newly diagnosed MM...
Research Review: Multiple Myeloma Summit
Research Review Multiple Myeloma Summit Highlights include:Â High risk MM outcomes 5-year results for CyBorD MRD for guiding myeloma treatment...
Research Review: Multiple Myeloma – Issue 28
Issue 28 of Multiple Myeloma Research Review. Highlights include:Â Elotuzumab monotherapy for smouldering MM Thereapetuc vulnerability of MM to...
Research Review: Multiple Myeloma – Issue 27
Issue 27 of Multiple Myeloma Research Review Highlights include:Â Low dose lenalidomide + dexamethasone in newly diagnosed POEMS syndrome. Loss of...
Research Review: Multiple Myeloma – Issue 26
Issue 26 of Multiple Myeloma Research Review. Highlights include:Â Selinexor in relapsed/refractory multiple myeloma HIV antivirals overcome...
Research Review – ANZMAP Multiple Myeloma Highlights
ANZMAP Multiple Myeloma Highlights from ASH 2017 This publication provides summaries of key clinically relevant multiple myeloma data presented at...
Research Review: Multiple Myeloma – Issue 25
Issue 25 of Multiple Myeloma Research Review. Highlights include: Induction VCD. Prediction of outcome in newly diagnosed myeloma Final...
Research Review: Multiple Myeloma – Issue 24
Issue 24 of Multiple Myeloma Research Review. Highlights include: Is MRD the best predictor of response? ctDNA and risk of distant relapse....
Research Review: Multiple Myeloma – Issue 23
Issue 23 of Multiple Myeloma Research Review. Highlights include: • Revised Myeloma Comorbidity index for multiple myeloma prognosis. •...
Expert Forum: Myeloma Summit August 2016
This publication is a summary of selected presentations delivered at the Haematology Society of Australia and New Zealand (HSANZ) Inaugural...
Research Review: Multiple Myeloma – Issue 22
Issue 22 of Multiple Myeloma Research Review. Highlights include: •  Benefits of low dose lenalidomide in relapsed/refractory MM. •  Network...